FDA
-
-
-
-
-
-
-
Iterum expands ORLYNVAH coverage, secures Medicare Part D agreement
-
-
-
-
-
-
-
Iterum Therapeutics Provides Business Update
-
-
-
-
-
-
-
Iterum Therapeutics Announces Publication of REASSURE Trial in NEJM Evidence
-
-
-
-
-
-
-
Iterum Therapeutics Plc (ITRM) Announces $5 Million Registered Direct Offering of Ordinary Shares
-
-
-
-
-
-
-
Iterum Therapeutics Reports Third Quarter 2024 Financial Results
-
-
-
-
-
-
-
Iterum Therapeutics to Participate at the 2024 Maxim Healthcare Virtual Summit
-
-
-
-
-
-
-
Iterum Therapeutics to Report Second Quarter 2024 Financial Results on August 14, 2024
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

